There are specific circumstances in which you should seek prompt medical advice, either from your trial team or your GP: Persistent insomnia lasting more than three to four weeks that is significantly affecting your daytime functioning, mood, or concentration Symptoms of anxiety or low mood that have developed or worsened since starting treatment, as these can both cause and be exacerbated by poor sleep Signs of obstructive sleep apnoea such as loud snoring, gasping during sleep (reported by a partner), or excessive daytime sleepiness which require formal assessment and may need referral to a sleep clinic New or worsening palpitations or an irregular heartbeat at night GLP-1-based medicines can be associated with a modest increase in resting heart rate
This saves time and frustration (for both the patient and the clinician)
Storage matters for potency
Dose and titration speed This is the single biggest variable
Normally, compounding a commercially available drug isnt permitted
Those bacteria ferment it and produce short-chain fatty acids like acetate, propionate, and butyrate